iSpecimen Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $151.9K | $156.0K | $51.8K | $106.6K | $713.1K | $1.1M | $1.5M | $2.7M |
| Cost of Revenue | $83.3K | $84.4K | $455.2K | $204.6K | $444.2K | $609.4K | $1.2M | $1.6M |
| Gross Profit | $68.7K | $71.6K | $-403.4K | $-98.0K | $269.0K | $448.1K | $295.0K | $1.1M |
| Gross Margin | 45.2% | 45.9% | -779.4% | -91.9% | 37.7% | 42.4% | 20.0% | 41.6% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $442.5K | $680.4K | $901.1K | $864.1K | $948.4K | $758.7K | $2.0M | $892.7K |
| Operating Income | $-1.4M | $-2.5M | $-2.7M | $-2.8M | $-1.8M | $-1.6M | $-5.8M | $-1.7M |
| Operating Margin | -897.1% | -1,627.1% | -5,192.9% | -2,655.2% | -255.4% | -154.9% | -395.8% | -64.1% |
| Interest Expense | — | — | — | — | — | — | — | $7.4K |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-1.4M | $-2.3M | $-5.0M | $-2.8M | $-1.0M | $-1.7M | $-6.0M | $-1.4M |
| Net Margin | -896.9% | -1,458.4% | -9,662.2% | -2,608.7% | -146.9% | -156.8% | -409.8% | -54.1% |
| EPS (Basic) | $-0.98 | $-6.66 | $43.53 | $-0.08 | $-2.80 | $-4.76 | $-0.90 | $-0.35 |
| EPS (Diluted) | $-0.98 | $-6.66 | $43.53 | $-0.08 | $-2.80 | $-4.76 | $-0.90 | $-0.35 |
| Shares Outstanding (Basic) | 1.4M | 341.4K | 4.6M | 35.0M | 374.5K | 348.5K | 4.3M | 4.1M |
| Shares Outstanding (Diluted) | 1.4M | 341.4K | 4.6M | 35.0M | 374.5K | 348.5K | 4.3M | 4.1M |
| Dividends Per Share | — | — | — | — | — | — | — | — |